Leading Suppliers of Methyldopa API
Several manufacturers and suppliers provide methyldopa active pharmaceutical ingredient (API). Companies like Amoli Organics Pvt. Ltd., Bafna Pharmaceuticals Ltd., and Rochem International Inc. are among those offering methyldopa API [1, 2, 3]. Other suppliers include Ancalima Lifesciences, Macleods Pharmaceuticals Ltd., and Wuhan Fortuna Chemical Co., Ltd. [4, 5, 6].
What is Methyldopa Used For?
Methyldopa is a medication primarily used to treat high blood pressure, also known as hypertension [7]. It is often prescribed for pregnant women with hypertension, as it is generally considered safe for both the mother and the baby [8].
How Does Methyldopa Work?
Methyldopa is a centrally acting alpha-adrenergic agonist. It works by stimulating alpha-adrenergic receptors in the brain, which reduces sympathetic outflow from the central nervous system. This leads to a decrease in heart rate, peripheral vascular resistance, and blood pressure [7].
When Might Methyldopa's Patent Exclusivity End?
Information regarding specific patent exclusivity periods for methyldopa is not readily available in the provided context. Drug patent information, including expiry dates and any challenges to those patents, can be tracked through specialized databases [9].
Are There Alternatives to Methyldopa?
Yes, there are several alternative medications for treating high blood pressure. These include other classes of antihypertensives such as diuretics, beta-blockers, calcium channel blockers, and ACE inhibitors. The choice of medication depends on individual patient factors, including the severity of hypertension, other medical conditions, and potential side effects [8].
How is Methyldopa API Regulated?
The production and supply of methyldopa API are subject to strict regulatory standards to ensure quality, safety, and efficacy. Regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) oversee the manufacturing processes and quality control of APIs through Good Manufacturing Practices (GMP) [10].
Sources:
[1] https://www.drugpatentwatch.com/api-suppliers/amoli-organics-pvt-ltd
[2] https://www.drugpatentwatch.com/api-suppliers/bafna-pharmaceuticals-ltd
[3] https://www.drugpatentwatch.com/api-suppliers/rochem-international-inc
[4] https://www.drugpatentwatch.com/api-suppliers/ancalima-lifesciences
[5] https://www.drugpatentwatch.com/api-suppliers/macleods-pharmaceuticals-ltd
[6] https://www.drugpatentwatch.com/api-suppliers/wuhan-fortuna-chemical-co-ltd
[7] https://www.nhs.uk/medicines/methyldopa/
[8] https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/blood-pressure-medications/art-20045125
[9] https://drugpatentwatch.com/
[10] https://www.fda.gov/drugs/pharmaceutical-manufacturing/current-good-manufacturing-practice-regulation-21-cfr-part-210-and-211